PainReform Ltd. Ordinary Shares
Symbol: PRFX (NASDAQ)
1.30
▼ (-9.44%) -0.135
Company Description:
PainReform Ltd is a clinical-stage specialty pharmaceutical company. It is focused on the reformulation of established therapeutics. The company's product PRF-110 is based on the local anesthetic ropivacaine, targeting the post-operative pain relief market. PRF-110 is an oil-based, viscous, clear solution that is deposited directly into the surgical wound bed before closure to provide localized and extended post-operative analgesia.
Key Stats
- Today's Open: $1.34
- Today's High: $1.35
- Today's Low: $1.295
- Today's Volume: 15.31K
- Yesterday Close: $1.43
- Yesterday High: $1.47
- Yesterday Low: $1.39
- Yesterday Volume: 276.07K
- Last Min Volume: 1.00K
- Last Min High: $1.295
- Last Min Low: $1.295
- Last Min VWAP: $1.295
Company Profile
- Name: PainReform Ltd. Ordinary Shares
- Website: https://www.painreform.com
- Listed Date: 2020-09-01
- Location: ,
- Market Status: Active
- CIK Number: 0001801834
- SIC Code:
- SIC description:
- Market Cap: $2.66M
- Round Lot: 100
- Outstanding Shares: 2.01M
- Asset Type: CS
RECENT FILINGS FOR PRFX
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-07-10 | 6-K | View |
| 2025-05-09 | EFFECT | View |
| 2025-05-09 | 424B3 | View |
| 2025-05-07 | CORRESP | View |
| 2025-05-07 | 6-K | View |
| 2025-05-07 | UPLOAD | View |
| 2025-05-02 | F-3 | View |
| 2025-04-24 | SCHEDULE 13G | View |
| 2025-04-17 | 6-K | View |
| 2025-04-11 | 6-K | View |
| 2025-04-10 | 6-K | View |
| 2025-04-07 | 6-K | View |
| 2025-04-07 | 20-F | View |
| 2025-04-03 | 6-K | View |
| 2025-03-05 | 6-K | View |
| 2025-02-27 | 6-K | View |
| 2025-02-26 | 6-K | View |
| 2025-02-18 | 6-K | View |
| 2025-01-02 | 424B5 | View |
| 2025-01-02 | 6-K | View |
Latest News on PRFX